Trial intelligence / Profile preview

ACTS-GC adjuvant TS-1 for gastric cancer

jRCT1080220047Phase 3

Sponsor
Taiho Pharmaceutical Co., Ltd.
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tegafur in gastric cancer (GC), sponsored by Taiho Pharmaceutical Co., Ltd.

02

Drugs

tegafur
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on jRCT1080220047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080220047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call